These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18656899)

  • 1. The effectiveness of two COX-2 inhibitors in the prophylaxis against heterotopic new bone formation: an experimental study in rabbits.
    Tsailas PG; Babis GC; Nikolopoulos K; Soucacos PN; Korres DS
    J Surg Res; 2009 Jan; 151(1):108-14. PubMed ID: 18656899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam.
    Barthel T; Baumann B; Nöth U; Eulert J
    Acta Orthop Scand; 2002 Dec; 73(6):611-4. PubMed ID: 12553505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty.
    Legenstein R; Bösch P; Ungersböck A
    Arch Orthop Trauma Surg; 2003 Apr; 123(2-3):91-4. PubMed ID: 12664317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis for heterotopic ossification after primary total hip arthroplasty. A cohort study between indomethacin and meloxicam.
    van der Heide HJ; Spruit M; Slappendel R; Klooster N; van Limbeek J
    Acta Orthop Belg; 2004 Jun; 70(3):240-6. PubMed ID: 15287403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of Parecoxib or Meloxicam effect on acute postoperative pain after orthopedic surgical interventions: comparative study in hospitalized women and men.
    Kraevsky P; Kasakov L; Vlaskovska M
    Khirurgiia (Sofiia); 2011; (1):28-32. PubMed ID: 23847799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of selective and non-selective cyclooxygenase 2 inhibitors on heterotopic ossification in rat model with Achilles tenotomy].
    Wu J; Xiao H; Xue F; Shi W; Zhao H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Mar; 28(3):371-6. PubMed ID: 24844023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The non-steroidal anti-inflammatory drugs protect mouse cochlea against acoustic injury.
    Hoshino T; Tabuchi K; Hirose Y; Uemaetomari I; Murashita H; Tobita T; Hara A
    Tohoku J Exp Med; 2008 Sep; 216(1):53-9. PubMed ID: 18719338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robenacoxib versus meloxicam for the management of pain and inflammation associated with soft tissue surgery in dogs: a randomized, non-inferiority clinical trial.
    Gruet P; Seewald W; King JN
    BMC Vet Res; 2013 May; 9():92. PubMed ID: 23638669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meloxicam and selective COX-2 inhibitors in the management of pain in the palliative care population.
    Smith HS; Baird W
    Am J Hosp Palliat Care; 2003; 20(4):297-306. PubMed ID: 12911075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free radical scavengers are more effective than indomethacin in the prevention of experimentally induced heterotopic ossification.
    Vanden Bossche LC; Van Maele G; Wojtowicz I; De Cock K; Vertriest S; De Muynck M; Rimbaut S; Vanderstraeten GG
    J Orthop Res; 2007 Feb; 25(2):267-72. PubMed ID: 17106886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
    Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
    Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2 inhibition decreases VEGF expression and alveolar bone loss during the progression of experimental periodontitis in rats.
    Oliveira TM; Sakai VT; Machado MA; Dionísio TJ; Cestari TM; Taga R; Amaral SL; Santos CF
    J Periodontol; 2008 Jun; 79(6):1062-9. PubMed ID: 18533784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of a multimodal analgesia protocol in preventing heterotopic ossification after acetabular fractures surgery.
    Cheng L; Long HT; Sun BH; Zhao SS; Zhu Y
    Int J Clin Pharm; 2017 Aug; 39(4):826-830. PubMed ID: 28500436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of antiallodynic effects of the cyclooxygenase-2 inhibitor meloxicam on established diabetic neuropathic pain in mice.
    Kimura S; Kontani H
    J Pharmacol Sci; 2009 Jun; 110(2):213-7. PubMed ID: 19498273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of the cyclooxygenase-2 (COX-2) inhibitor meloxicam blocks ovulation in non-human primates when administered to simulate emergency contraception.
    Hester KE; Harper MJ; Duffy DM
    Hum Reprod; 2010 Feb; 25(2):360-7. PubMed ID: 19965877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats.
    Bezerra MM; de Lima V; Alencar VB; Vieira IB; Brito GA; Ribeiro RA; Rocha FA
    J Periodontol; 2000 Jun; 71(6):1009-14. PubMed ID: 10914805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective COX-2 inhibitor reduces bone healing in bone defects.
    Gurgel BC; Ribeiro FV; Silva MA; Nociti FH; Sallum AW; Sallum EA; Toledo Sd; Casati MZ
    Braz Oral Res; 2005; 19(4):312-6. PubMed ID: 16491262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal timing of preoperative radiation for prophylaxis against heterotopic ossification. A rabbit hip model.
    Rumi MN; Deol GS; Bergandi JA; Singapuri KP; Pellegrini VD
    J Bone Joint Surg Am; 2005 Feb; 87(2):366-73. PubMed ID: 15687161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective cyclooxygenase-2 inhibitor may impair bone healing around titanium implants in rats.
    Ribeiro FV; César-Neto JB; Nociti FH; Sallum EA; Sallum AW; De Toledo S; Casati MZ
    J Periodontol; 2006 Oct; 77(10):1731-5. PubMed ID: 17032117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase inhibitors decrease the growth and induce regression of human esophageal adenocarcinoma xenografts in nude mice.
    Santander S; Cebrián C; Esquivias P; Conde B; Esteva F; Jiménez P; Ortego J; Lanas A; Piazuelo E
    Int J Oncol; 2012 Feb; 40(2):527-34. PubMed ID: 21971589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.